Contents hide 1 Rheumatoid Arthritis 2 Psoriatic Arthritis 3 Atopic Dermatitis 3.1 <65 years 4 Ulcerative Colitis 4.1 Maintenance 5 Ankylosing Spondylitis 6 Nonradiographic Axial Spondyloarthritis 7 Crohn Disease 8 Dosage Modifications 8.1 Coadministration of strong CYP3A4 inhibitors 8.2 Infection 8.3 Dose interruption for laboratory abnormalities 8.4 Renal impairment 8.4.1 RA, PsA, AS, or nr-axSpA 8.4.2 AD 8.4.3 UC 8.4.4 Crohn disease 8.5 Hepatic impairment 8.5.1 UC 8.5.2 Crohn disease 9 Dosing Considerations 9.1 Before initiating 9.2 Limitations of use Upadacitinib is a medication used for the treatment of rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn’s disease, ankylosing spondylitis, and axial spondyloarthritis.Upadacitinib is a Janus kinase (JAK) … Continue reading Generic (Upadacitinib) UPADX